Chunli Medical (01858.HK) (688236.SH) announced that Chairman Shi Wenling proposed that the company repurchase A shares through the Shanghai Stock Exchange using centralized competitive bidding trading, involving self-owned funds of RMB 20-40 million, and the maximum repurchase share price should not exceed 150% of the average stock trading price in the 30 trading days before the board of directors approves the repurchase plan. The repurchased shares will be used for implementing employee stock ownership plans or stock-based incentive. If the repurchased shares are not fully utilized within three years after the announcement of the repurchase results, the unused repurchased shares will be cancelled. The repurchase period is within 12 months from the approval of the plan.

The repurchased shares will be used for implementing employee stock ownership plans or stock-based incentive. If the repurchased shares are not fully utilized within three years after the announcement of the repurchase results, the unused repurchased shares will be cancelled. The repurchase period is within 12 months from the approval of the plan.